剂量优化:开发瘤学药物的监管前景
Atiqur Rahman1, Mirat Shah2, Stacy S Shord1
1Division of Cancer Pharmacology II, Office of Clinical Pharmacology, Office of Translational Sciences, US Food and Drug Administration, Silver Spring, Maryland, USA.
在癌症治疗中优化药物剂量对于开发有效和耐受瘤疗法至关重要. 该项目旨在从传统的化疗剂量转向针对性,免疫和细胞疗法的个性化方法.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 药物开发 药物开发
背景情况:
- 优化药物剂量对于有效和耐受性良好的癌症治疗至关重要.
- 目前用于细胞毒性化疗的剂量范式,对于新型向疗法,免疫疗法和细胞疗法是不够的.
- 患者和倡导者对更耐受治疗的需求推动了改革的必要性.
研究的目的:
- 改革瘤药物开发中的剂量优化和选择范式.
- 为解决新癌症疗法目前剂量策略的局限性.
- 突出在建立最佳剂量以改善患者的治疗结果方面面临的挑战和机会.
主要方法:
- 审查从细胞毒性化疗到向,免疫和细胞疗法剂量所需的范式转变.
- 在药物开发过程中分析有限剂量表征的影响.
- 利用定量方法,创新的试验设计和监管支持.
主要成果:
- 不充分的剂量表征可能导致耐受性差,试验失败和市场撤回.
- 要考虑新型瘤学药物类别的独特属性,需要进行范式转变.
- 在整个开发过程中对数据的反复分析对于有利的利益风险概况至关重要.
结论:
- 采用新的剂量模式对于实现现代瘤治疗的全部潜力至关重要.
- 优化剂量策略可以提高药物的有效性和患者的耐受性.
- 及时获得有效的癌症药物取决于整个开发过程中的强大的剂量优化.
更多相关视频
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
09:19Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
相关概念视频
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Rational Dosage Regimen: Maintenance Dose and Loading Dose
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
Dosage Regimen: Fixed Dose
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Nonlinear Pharmacokinetics: Overview
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Factors Affecting Drug Response: Overview
Drug Regulation
